"Recent clinical studiesEtiologyPotentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus.Groeneveld ON, Kappelle LJ, Biessels GJJ Diabetes Investig 2016 Jan;7 (1):5-16. Epub 2015 Oct 3 doi: 10.1111/jdi.12420. PMID: 26816596 Free PMC ArticleUse of incretin agents and risk of pancreatic cancer: a population-based cohort study.Knapen LM, van Dalem J, Keulemans YC, van Erp NP, Bazelier MT, De Bruin ML, Leufkens HG, Croes S, Neef C, de Vries F, Driessen JHDiabetes Obes Metab 2016 Mar;18 (3):258-65. Epub 2016 Jan 8 doi: 10.1111/dom.12605. PMID: 26537555Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.Nauck MDiabetes Obes Metab 2016 Mar;18 (3):203-16. Epub 2016 Jan 5 doi: 10.1111/dom.12591. PMID: 26489970 Free PMC ArticleIncretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.Østoft SHDan Med J 2015 Sep;62 (9) PMID: 26324089Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.Gyldenløve M, Vilsbøll T, Zachariae C, Holst JJ, Knop FK, Skov LJ Intern Med 2015 Dec;278 (6):660-70. Epub 2015 Jul 14 doi: 10.1111/joim.12388. PMID: 26174490See all (816)DiagnosisIncretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.Østoft SHDan Med J 2015 Sep;62 (9) PMID: 26324089Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.Gyldenløve M, Vilsbøll T, Zachariae C, Holst JJ, Knop FK, Skov LJ Intern Med 2015 Dec;278 (6):660-70. Epub 2015 Jul 14 doi: 10.1111/joim.12388. PMID: 26174490Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.Soranna D, Bosetti C, Casula M, Tragni E, Catapano AL, Vecchia CL, Merlino L, Corrao GDiabetes Res Clin Pract 2015 May;108 (2):243-9. Epub 2015 Feb 23 doi: 10.1016/j.diabres.2015.02.013. PMID: 25748827Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.Novaes FS, Vasques AC, Pareja JC, Knop FK, Tura A, Chaim ÉA, Geloneze BJ Clin Endocrinol Metab 2015 May;100 (5):1984-8. Epub 2015 Mar 5 doi: 10.1210/jc.2014-4042. PMID: 25742514Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.Mari A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll TPLoS One 2013 Sep 3;8 (9):e73154. doi: 10.1371/journal.pone.0073154. PMID: 24019903 Free PMC ArticleSee all (356)TherapyPotentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus.Groeneveld ON, Kappelle LJ, Biessels GJJ Diabetes Investig 2016 Jan;7 (1):5-16. Epub 2015 Oct 3 doi: 10.1111/jdi.12420. PMID: 26816596 Free PMC ArticleUse of incretin agents and risk of pancreatic cancer: a population-based cohort study.Knapen LM, van Dalem J, Keulemans YC, van Erp NP, Bazelier MT, De Bruin ML, Leufkens HG, Croes S, Neef C, de Vries F, Driessen JHDiabetes Obes Metab 2016 Mar;18 (3):258-65. Epub 2016 Jan 8 doi: 10.1111/dom.12605. PMID: 26537555Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.Nauck MDiabetes Obes Metab 2016 Mar;18 (3):203-16. Epub 2016 Jan 5 doi: 10.1111/dom.12591. PMID: 26489970 Free PMC ArticleThe incretin effect in critically ill patients: a case-control study.Nielsen ST, Janum S, Krogh-Madsen R, Solomon TP, Møller KCrit Care 2015 Nov 16;19:402. doi: 10.1186/s13054-015-1118-z. PMID: 26567860 Free PMC ArticleIncretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.Østoft SHDan Med J 2015 Sep;62 (9) PMID: 26324089See all (1326)PrognosisUse of incretin agents and risk of pancreatic cancer: a population-based cohort study.Knapen LM, van Dalem J, Keulemans YC, van Erp NP, Bazelier MT, De Bruin ML, Leufkens HG, Croes S, Neef C, de Vries F, Driessen JHDiabetes Obes Metab 2016 Mar;18 (3):258-65. Epub 2016 Jan 8 doi: 10.1111/dom.12605. PMID: 26537555Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.Deng Y, Zhang Y, Zheng S, Hong J, Wang C, Liu T, Sun Z, Gu W, Gu Y, Shi J, Yao S, Wang W, Ning GJ Diabetes 2015 Nov;7 (6):820-9. Epub 2015 Mar 4 doi: 10.1111/1753-0407.12245. PMID: 25395350Incretin-mimetic therapies and pancreatic disease: a review of observational data.Suarez EA, Koro CE, Christian JB, Spector AD, Araujo AB, Abraham SCurr Med Res Opin 2014 Dec;30 (12):2471-81. Epub 2014 Sep 16 doi: 10.1185/03007995.2014.960515. PMID: 25180611Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study.Faillie JL, Azoulay L, Patenaude V, Hillaire-Buys D, Suissa SBMJ 2014 Apr 24;348:g2780. PMID: 24764569 Free PMC ArticleSimulation of oral glucose tolerance tests and the corresponding isoglycemic intravenous glucose infusion studies for calculation of the incretin effect.Kim M, Oh TJ, Lee JC, Choi K, Kim MY, Kim HC, Cho YM, Kim SJ Korean Med Sci 2014 Mar;29 (3):378-85. Epub 2014 Feb 27 doi: 10.3346/jkms.2014.29.3.378. PMID: 24616587 Free PMC ArticleSee all (145)Clinical prediction guidesAn updated review on cancer risk associated with incretin mimetics and enhancers.Tseng CH, Lee KY, Tseng FHJ Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2015;33 (1):67-124. doi: 10.1080/10590501.2015.1003496. PMID: 25803196Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.Soranna D, Bosetti C, Casula M, Tragni E, Catapano AL, Vecchia CL, Merlino L, Corrao GDiabetes Res Clin Pract 2015 May;108 (2):243-9. Epub 2015 Feb 23 doi: 10.1016/j.diabres.2015.02.013. PMID: 25748827Implications of incretin-based therapies on cardiovascular disease.Rotz ME, Ganetsky VS, Sen S, Thomas TFInt J Clin Pract 2015 May;69 (5):531-49. Epub 2014 Nov 1 doi: 10.1111/ijcp.12572. PMID: 25363540Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study.Faillie JL, Azoulay L, Patenaude V, Hillaire-Buys D, Suissa SBMJ 2014 Apr 24;348:g2780. PMID: 24764569 Free PMC ArticleMarked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PCDiabetes 2013 Jul;62 (7):2595-604. Epub 2013 Mar 22 doi: 10.2337/db12-1686. PMID: 23524641 Free PMC ArticleSee all (344)"
